SAN DIEGO, Nov. 14, 2024 /PRNewswire/ -- HUYABIO International today announced the presentation of new patient data for HBI-3000, an antiarrhythmic drug (AAD) with a unique protective profile for the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback